Nautilus Biotechnology Inc
(NAUT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 02-2000 | 11-1999 | 08-1999 | 05-1999 | 02-1999 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 46,160 | 36,090 | 28,380 | 4,360 | 58,700 |
| Depreciation Amortization | 17,070 | 13,220 | 8,890 | 4,370 | 12,550 |
| Other Working Capital | -930 | -6,110 | -23,500 | 11,410 | -9,630 |
| Other Operating Activity | 380 | 750 | 370 | 60 | -990 |
| Operating Cash Flow | $62,680 | $43,950 | $14,140 | $20,200 | $60,630 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -33,280 | -24,290 | -15,730 | -6,820 | -20,220 |
| Net Acquisitions | 0 | 0 | 0 | 0 | -1,650 |
| Other Investing Activity | 20,830 | 21,070 | 26,190 | 2,480 | -2,930 |
| Investing Cash Flow | $-12,450 | $-3,220 | $10,460 | $-4,340 | $-24,800 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -38,590 | -29,140 | -29,220 | -29,410 | -54,940 |
| Financing Cash Flow | $-38,590 | $-29,140 | $-29,220 | $-29,410 | $-54,940 |
| Beginning Cash Position | 15,490 | 15,490 | 15,490 | 15,490 | 34,610 |
| End Cash Position | 27,140 | 27,080 | 10,880 | 1,930 | 15,490 |
| Net Cash Flow | $11,640 | $11,580 | $-4,610 | $-13,560 | $-19,110 |
| Free Cash Flow | |||||
| Operating Cash Flow | 62,680 | 43,950 | 14,140 | 20,200 | 60,630 |
| Free Cash Flow | 62,680 | 43,950 | 14,140 | 20,200 | 60,630 |